Nifuratel in chronic urinary infections.
D000368:Aged; D000818:Animals; D002177:Candidiasis / Q000188:drug therapy; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004927:Escherichia coli Infections / Q000188:drug therapy; D005260:Female; D005663:Furans / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007710:Klebsiella Infections / Q000188:drug therapy; D008297:Male; D051379:Mice; D008826:Microbial Sensitivity Tests; D010570:Pessaries; D011247:Pregnancy / Q000187:drug effects; D011270:Pregnancy, Animal / Q000187:drug effects; D011512:Proteus Infections / Q000188:drug therapy; D011552:Pseudomonas Infections / Q000188:drug therapy; D051381:Rats; D013290:Streptococcal Infections / Q000188:drug therapy; D014245:Trichomonas Infections / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000382:microbiology
D005663:Furans